Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#2 Victoria VR Victoria VR +11.93%
#3 Movement Movement +11.39%
#4 Palladium Network Palladium Network +9.28%
#5 DMT-NAT DMT-NAT +6.25%
#6 Cryptopia Cryptopia +4.73%
#7 Pons Pons +4.23%
#8 GRVT Token GRVT Token +3.85%
#9 MarsCoin MarsCoin +3.69%
#10 COTI COTI +3.65%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Response Genetics, Inc Response Genetics, Inc

Response Genetics, Inc

RGDXQ
Rang in Aktien #42156
Response Genetics, Inc., a life sciences company founded in Los Angeles,... Response Genetics, Inc., a life sciences company founded in Los Angeles, California, in 1999 (originally Bio Type, Inc., before its rebranding in August 2000), focuses on creating, advancing, and commercializing pharmacogenomic tests. These diagnostic tools are crucial for informing cancer treatment decisions by assessing specific indicators within tumor tissue samples that predict a patient's response to therapy. The company provides an extensive array of testing services, primarily through its ResponseDX suite, covering various cancers such as non-small cell lung, colorectal, gastric, gastroesophageal, melanoma, thyroid, breast, and glioma, in addition to a Tissue of Origin test. Beyond these existing solutions, Response Genetics is committed to expanding its diagnostic offerings to encompass other tumor types, while also delivering both the technical execution and professional interpretation components of its testing services. Operating globally, with a significant presence in the United States and Europe, Response Genetics serves a wide range of clients including community oncologists, pathologists, medical practices, hospitals, and pharmaceutical enterprises, primarily through its internal sales force.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$3.87K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Response Genetics, Inc (RGDXQ)

Kategorie

Healthcare
Kursverlauf für Response Genetics, Inc (RGDXQ)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $7.03 am 2007-06-01
Kursverlauf der Aktie von Response Genetics, Inc von 2007 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 -4.50%
2024 0.00%
2023 0.00%
2022 0.00%
2021 -94.93%
2020 -34.49%
2019 173.37%
2018 139.73%
2017 -62.56%
2016 -30.35%
2015 -99.59%
2014 -64.96%
2013 -10.96%
2012 0.43%
2011 -42.83%
2010 90.14%
2009 -29.87%
2008 -58.95%
2007 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $603.20 24.43%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $206.22 -1.40%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 $23.05 68.52%
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $572.21 -13.81%
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $314.70 99.56%
US